Publications

Export 28 results:
Author Title Type [ Year(Asc)]
Filters: Keyword is Schizophrenia  [Clear All Filters]
2015
Baldwin CH, Srivastava LK.  2015.  Can the neurodevelopmental theory account for sex differences in schizophrenia across the life span? J Psychiatry Neurosci. 40(2):75-7.
Bhardwaj SK, Stojkovic K, Kiessling S, Srivastava LK, Cermakian N.  2015.  Constant light uncovers behavioral effects of a mutation in the schizophrenia risk gene Dtnbp1 in mice.. Behav Brain Res. 284:58-68.
Keshavan MS, Mehta UMeherwan, Padmanabhan JL, Shah JL.  2015.  Dysplasticity, metaplasticity, and schizophrenia: Implications for risk, illness, and novel interventions.. Dev Psychopathol. 27(2):615-35.
Wheeler AL, Wessa M, Szeszko PR, Foussias G, Chakravarty MM, Lerch JP, DeRosse P, Remington G, Mulsant BH, Linke J et al..  2015.  Further neuroimaging evidence for the deficit subtype of schizophrenia: a cortical connectomics analysis.. JAMA Psychiatry. 72(5):446-55.
Gerretsen P, Menon M, Chakravarty MM, Lerch JP, Mamo DC, Remington G, Pollock BG, Graff-Guerrero A.  2015.  Illness denial in schizophrenia spectrum disorders: a function of left hemisphere dominance.. Hum Brain Mapp. 36(1):213-25.
Girard SL, Dion PA, Bourassa CV, Geoffroy S, Lachance-Touchette P, Barhdadi A, Langlois M, Joober R, Krebs M-O, Dubé M-P et al..  2015.  Mutation burden of rare variants in schizophrenia candidate genes.. PLoS One. 10(6):e0128988.
Behdinan T, Foussias G, Wheeler AL, Stefanik L, Felsky D, Remington G, Rajji TK, Chakravarty MM, Voineskos AN.  2015.  Neuroimaging predictors of functional outcomes in schizophrenia at baseline and 6-month follow-up.. Schizophr Res. 169(1-3):69-75.
Shah JL, Tandon N, Howard ER, Mermon D, Miewald JM, Montrose DM, Keshavan MS.  2015.  Pituitary volume and clinical trajectory in young relatives at risk for schizophrenia.. Psychol Med. 45(13):2813-24.
Whitley R, Palmer V, Gunn J.  2015.  Recovery from severe mental illness.. CMAJ. 187(13):951-2.
Lepage M, Hawco C, Bodnar M.  2015.  Relational Memory as a Possible Neurocognitive Marker of Schizophrenia.. JAMA Psychiatry. 72(9):946-7.
Lal S, Malla A.  2015.  Service Engagement in First-Episode Psychosis: Current Issues and Future Directions.. Can J Psychiatry. 60(8):341-5.
Chakravarty MM, Rapoport JL, Giedd JN, Raznahan A, Shaw P, D Collins L, Lerch JP, Gogtay N.  2015.  Striatal shape abnormalities as novel neurodevelopmental endophenotypes in schizophrenia: a longitudinal study.. Hum Brain Mapp. 36(4):1458-69.
Haro JMaria, Altamura C, Corral R, Elkis H, Evans J, Malla A, Krebs M-O, Zink M, Bernasconi C, Lalonde J et al..  2015.  Understanding the impact of persistent symptoms in schizophrenia: Cross-sectional findings from the Pattern study.. Schizophr Res. 169(1-3):234-40.

Pages